Dr. Jonathan S. Silbiger, MD

Dr. Silbiger practices at Advanced Eye Care in Orlando, Florida.

Dr. Silbiger's NPI, 1174520423, was assigned on July 1, 2005. Dr. Silbiger graduated from University Of Florida College Of Medicine in 1992. Dr. Silbiger holds Florida license ME64428.

Dr. Silbiger's primary practice is Advanced Eye Care, at 1911 N Mills Ave, Orlando, FL 32803 in Orange County. The practice phone is (407) 893-8200.

Dr. Silbiger's primary practice is Advanced Eye Care in Orlando, Florida. Dmand AI also links Dr. Silbiger to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silbiger practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Silbiger's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Silbiger is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Silbiger's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Silbiger treats.

CMS data shows 1,867 Medicare services from Dr. Silbiger across 14 procedure codes in 2024, for 721 Medicare patients. Medicare paid $180,936 for them.

CMS counts 721 Medicare patients who saw Dr. Silbiger in 2024. The largest group is 75 to 84, with 345 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Silbiger's median patient age at 75, with 60% women.

In 2024, Dr. Silbiger wrote 2,754 Medicare Part D claims for 798 patients. 57% of them were for generic drugs. CMS names the drug for 2,667 of them, across 25 drugs with 11 or more claims each, at $119,618 in total drug cost. In 2023, CMS named 2,393 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Silbiger for performance year 2024, reported as part of a group. Dr. Silbiger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 189 procedures of cataract surgery by Dr. Silbiger, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Silbiger. The most frequent topics are Hydrocortisone, Sheep and Adrenocorticotropic Hormone. Dr. Silbiger has published most often in Domest Anim Endocrinol.

CMS Open Payments shows 24 general payments to Dr. Silbiger from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Shire North American Group Inc paid the most, $325.

Dr. Silbiger graduated from University Of Florida College Of Medicine in 1992.

Dr. Silbiger is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.